Transense Technologies
TRT · AIM · Industrial Goods and Services · mcap £6.6m · 46.0p
Directors
purchase Transense Technologies plc announced that on March 13, 2026, Managing Director Ryan Maughan acquired 14,113 ordinary shares at 70.8 pence per share, increasing his beneficial holding to 106,154 shares, representing appro 13 Mar 2026
purchase Transense Technologies plc announced that on April 24, 2026, Managing Director Ryan Maughan purchased 3,409 ordinary shares at 58.44 pence per share, increasing his total beneficial shareholding to 109,563 shares, repres 24 Apr 2026
purchase Transense Technologies plc announced that on April 27, 2026, Executive Chairman Nigel Rogers purchased 12,500 ordinary shares at 57.98 pence per share, increasing his beneficial shareholding to 300,000 ordinary shares, r 27 Apr 2026
purchase Transense Technologies plc announced that on June 22, 2026, Managing Director Ryan Maughan purchased 16,654 ordinary shares at 47.99 pence per share, increasing his total beneficial holding to 126,217 shares, representin 22 Jun 2026
other Transense Technologies plc announced that Chief Financial Officer Melvyn Segal will retire in November 2026, after which he will remain as a non-executive director for one year. Richard Michael Pearce ACA has been appoin 7 Jul 2026
purchase Transense Technologies plc announced that on October 5, 2026, Managing Director Ryan Maughan acquired 23,002 ordinary shares at 43 pence per share, costing him £9,890.60. This transaction increases his total beneficial s 6 Oct 2026
Company filings. Not investment advice.